Skip to Content, Navigation, or Footer.
Friday, April 19
The Indiana Daily Student

A pregnant woman lays in a hospital bed. The FDA approved Zurzuvae, the first pill to treat postpartum depression, Aug. 4, 2023. Tribune News Service and Tribune News Service

cafdapostpartum08082.jpg

A pregnant woman lays in a hospital bed. The FDA approved Zurzuvae, the first pill to treat postpartum depression, Aug. 4, 2023.